Description
Please email Jackie – jstoddard@actrix.co.nz for a consultation on this product
Echinacea Premium 100% Cultivated Liquid Extract 1:2, 50 ml
Echinacea Premium combines the roots of Echinacea angustifolia and Echinacea purpurea to enlist properties unique to each. The blending of these two plant species ensures that the specific caffeic acid derivatives (cichoric acid, echinacoside, cynarin) and the lipophilic components (especially alkylamides) are present in appropriate quantities. This product is standardised to contain a total of 5.15 mg per tablet of alkylamides to ensure optimal strength and quality.
Mode of Action
Echinacea works to reduce the symptoms of mild upper respiratory complaints. May assist by reducing the severity and lead to earlier resolution of symptoms of mild upper respiratory infections, colds and flu. This product contains alkylamides, a class of Echinacea compounds that contribute to phagocyte-enhancing activity.
Indications
Relief of the symptoms of colds, influenza and other mild upper respiratory infections.
May reduce the incidence of mild upper respiratory tract infections
Build immunity prior to flying
Assist in building immuntiy for conditions such as skin disease, chronic fatigue syndrome, allergies and frequent and repetitive bouts of illness.
Contraindications and Cautions
The risk of allergic reaction to Echinacea is very small, especially if preparations of the root are used since these are free of pollens. Echinacea is contraindicated in patients taking immunosuppressant medication (eg transplant patients). Short-term therapy only is suggested in this instance. Caution is advised in patients receiving midazolam by injection. Discontinue 7 days prior to general anaesthesia.
Each tablet contains:
Echinacea angustifolia (Echinacea) extract equivalent to dry root
containing alkylamides 2.5 mg 600 mg
Echinacea purpurea (Echinacea) extract equivalent to dry root
containing alkylamides 2.65 mg 675 mg
